The steady global growth of the healthcare 3PL market is primarily attributed to the growing pharmaceutical industry, rising demand for biologics with increasing cold chain logistics needs followed by ...

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...

The AHA responds to the Health Resources and Services Administration’s (HRSA) Request for Information regarding a potential 340B Rebate Model Pilot Program.

Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates.  | The administration's second stab ...

The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...

The federal program was created in 1992 to help hospitals and clinics in poor communities. In recent weeks, it has become the ...

AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.

The 340B Drug Pricing Program cuts prescription drug costs for safety-net hospitals, which often invest the savings in patient care.

Continuing its 2025 promotional tour, Siborg Systems Inc. started 2026 with presentation of its award-winning LCR-Reader line ...